SciELO - Scientific Electronic Library Online

 
vol.57 issue1Epidural S(+) ketamine and S(+) ketamine-morphine associated with ropivacaine in the postoperative analgesia and sedation of upper abdominal surgeryEffect of pretreatment with lidocaine, intravenous paracetamol and lidocaine-fentanyl on propofol injection pain: comparative study author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Anestesiologia

Print version ISSN 0034-7094

Abstract

ISHIZUKA, Pedro et al. Assessment of oral S(+) ketamine associated with morphine for the treatment of oncologic pain. Rev. Bras. Anestesiol. [online]. 2007, vol.57, n.1, pp. 19-31. ISSN 0034-7094.  http://dx.doi.org/10.1590/S0034-70942007000100003.

BACKGROUND AND OBJECTIVES: Morphine is used frequently to treat oncologic pain. However, tolerance may develop with prolonged use. The association of a NMDA receptor antagonist may reduce or delay the onset of tolerance. S(+) ketamine seems to be more potent and with fewer side effects. The aim of this study was to evaluate the association of S(+) ketamine and morphine in the treatment of oncologic pain. METHODS: Thirty patients, randomly divided in two groups, participated in this double-blind study. Patients in G1 received 10 mg of morphine PO every 6 hours and 10 mg of S(+) ketamine PO every 8 hours. Patients in G2 received 10 mg of morphine PO every 6 hours and placebo PO every 8 hours. The dose of morphine was adjusted by 5 mg increments whenever necessary. Pain severity was evaluated through a verbal scale. RESULTS: The percentage of no pain and mild pain was similar in both groups (G1 = 0 and G2 = 0 at M0; G1 = 22.2 and G2 = 53.8 at M1; G1 = 22.2 and G2 = 61.5 at M2; G1 = 44.6 and G2 = 61.5 at M3; and G1 = 44.5 and G2 = 53.8 at M4); Chi-square test. The percentage of moderate relief and complete relief was similar in both groups (G1 = 33.4 and G2 = 53.9 after one week; G1 = 44.4 and G2 = 69.2 after two weeks; G1 = 66.6 and G2 = 69.2 after three weeks; and G1 = 55.6 and G2 = 53.9 after four weeks); Chi-square test. The need to increase the dose of morphine was also similar in both groups (G1 = 2.22 and G2 = 2.15); Mann-Whitney test. CONCLUSIONS: We did not observe an increase on the analgesic effects of morphine with the association of 10 mg of S(+) ketamine PO in the treatment of oncologic pain.

Keywords : ANALGESICS, Opioids [morphine]; ketamine; PAIN, oncologic.

        · abstract in Portuguese | Spanish     · text in English | Portuguese     · pdf in English | Portuguese